ENTITY
CSPC Innovation Pharmaceutical-A

CSPC Innovation Pharmaceutical-A (300765 CH)

36
Analysis
Health Care • China
CSPC Innovation Pharmaceutical Co.,Ltd. manufactures bulk pharmaceutical chemical products. The Company develops and markets diprophylline, theobromine, pentoxifylline, doxofylline, psychotropic drugs, and other products. CSPC Innovation Pharmaceutical also produces vitamin products, functional foods, and other products.
more
•18 Dec 2025 16:30

CSPC Innovation (石药创新) A+H Pre-IPO Quick Comment: Me-Toos Overweigh Innovative Candidates

Chinext listed ​CSPC Innovation plans to raise $100 million through A+H listing. We assessed  the product pipeline of its biopharm business in this...

Logo
346 Views
Share
•16 Dec 2025 08:30

CSPC Innovation (300765 CH) A/H Listing: Shifting Focus to Biopharma Augurs Well

CSPC Innovation has applied for H share listing. The company intends to raise fund for financing biopharmaceuticals R&D, acquisition, and...

Logo
423 Views
Share
•03 Sep 2026 15:35

MS-China Index Earning Revision (Aug): KINGBOARD HLDG, LI AUTO, XIAOMI, TRINA SOLAR, TENCENT, PDD

We analyzed MS-China's consensus for Aug 2026 and highlighted changes of EPS in KINGBOARD HLDG, LI AUTO, XIAOMI, TRINA SOLAR, TENCENT, CHINA LIFE,...

Logo
109 Views
Share
•02 Apr 2026 11:15

MS-China Index Earning Revision (Mar): PDD, UNITED NOVA TECHNOLOGY, MEITUAN, TENCENT, ALIBABA

We analyzed MS-China's consensus for Mar 2026 and highlighted changes of EPS in PDD, UNITED NOVA TECHNOLOGY, MEITUAN, TENCENT, ALIBABA, TCL...

Logo
449 Views
Share
•22 Dec 2025 08:44

ECM Weekly (22 December 2025) - SBI Shinsei, ICICI AMC, Insilico, Forest Cabin Sanhua, IFBH, CaoCao

Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.

Logo
644 Views
Share
x